Efavirenz pharmacogenetics in a cohort of Italian patients-Reference-Cited by-同舟云学术

Efavirenz pharmacogenetics in a cohort of Italian patients

Published:2016-02 Issue:2 Volume:47 Page:117-123
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Cusato Jessica^ORCID,Tomasello Cristina,Simiele Marco,Calcagno Andrea,Bonora Stefano,Marinaro Letizia,Leggieri Anna,Allegra Sarah,Di Perri Giovanni,D’Avolio Antonio

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Italian HIV Guidelines Working Group. Italian guidelines for the use of antiretroviral agents and the diagnostic–clinical management of HIV-1 infected persons;Antinori;New Microbiol,2011

2. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011;Nelson;HIV Med,2011

3. Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection;Csajka;Clin Pharmacol Ther,2003

4. Efavirenz plasma concentrations in HIV-infected patients: inter- and intraindividual variability and clinical effects;Ståhle;Ther Drug Monit,2004

5. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients;Marzolini;AIDS,2001

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants;Diagnostics;2023-01-12

2. Influence of HNF4α and HNF4α-AS1 gene variants on the risk of anti-tuberculosis drugs-induced hepatotoxicity;Annals of Palliative Medicine;2021-11

3. The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV;Expert Opinion on Drug Metabolism & Toxicology;2021-04-29

4. Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa;International Journal of Infectious Diseases;2021-03

5. Pharmacogenomics and pharmacokinetics of efavirenz 400 or 600 mg in 184 treatment-naive HIV-infected patients in China;Pharmacogenomics;2020-08